Financial statements Fibiomed
Cash inflows of FIBIOMED
Year
|
2020
|
2022
|
2023
|
---|---|---|---|
Net cash from operating expenses | - | -4 532 146,81 | -4 145 447,64 |
Net cash flow from investing activities | - | -5 972,00 | -32 797,09 |
Net cash flow from financial activities | - | 2 410 230,17 | 4 042 421,98 |
Total net cash flow | - | -2 127 888,64 | -135 822,75 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.